Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine

被引：42

作者：

De Boer, RJ

Boucher, CAB

Perelson, AS

机构：

[1] Univ Utrecht, NL-3584 CH Utrecht, Netherlands

[2] Univ Utrecht Hosp, Eijkman Winkler Inst, Dept Virol, Utrecht, Netherlands

[3] Univ Calif Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA

来源：

AIDS | 1998年 / 12卷 / 13期

关键词：

hydroxyurea; immunosuppression; target cell availability; resistance;

D O I：

10.1097/00002030-199813000-00002

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1567 / 1570

页数：4

共 49 条

[1] EFFECTS OF CYCLOSPORIN ON T-CELL SUBSETS IN HUMAN IMMUNODEFICIENCY VIRUS-DISEASE [J].

ANDRIEU, JM ;

EVEN, P ;

VENET, A ;

TOURANI, JM ;

STERN, M ;

LOWENSTEIN, W ;

AUDROIN, C ;

EME, D ;

MASSON, D ;

SORS, H ;

ISRAELBIET, D ;

BELDJORD, K .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 47 (02) :181-198

[2] SUSTAINED INCREASES IN CD4 CELL COUNTS IN ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SEROPOSITIVE PATIENTS TREATED WITH PREDNISOLONE FOR 1 YEAR [J].

ANDRIEU, JM ;

LU, W ;

LEVY, R .

JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :523-530

[3] Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individuals [J].

Biron, F ;

Lucht, F ;

Peyramond, D ;

Fresard, A ;

Vallet, T ;

Nugier, F ;

Grange, J ;

Malley, S ;

HamediSangsari, F ;

Vila, J .

ANTIVIRAL RESEARCH, 1996, 29 (01) :111-113

[4] Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine [J].

Brichacek, B ;

Swindells, S ;

Janoff, EN ;

Pirruccello, S ;

Stevenson, M .

JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1191-1199

[5] Telomerase regulation during entry into the cell cycle in normal human T cells [J].

Buchkovich, KJ ;

Greider, CW .

MOLECULAR BIOLOGY OF THE CELL, 1996, 7 (09) :1443-1454

[6] Hepatitis B vaccination and plasma HIV-1 RNA [J].

Cheeseman, SH ;

Davaro, RE ;

Ellison, RT .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (19) :1272-1272

[7]

Clotet B, 1996, Antivir Ther, V1, P189

[8] HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].

COFFIN, JM .

SCIENCE, 1995, 267 (5197) :483-489

[9] AIDS research - HIV suppressed long after treatment [J].

Cohen, J .

SCIENCE, 1997, 277 (5334) :1927-1927

[10] REDUCING T-CELL ACTIVATION AS A THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].

COREY, L .

JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :521-522

← 1 2 3 4 5 →